Trial intelligence / Profile preview

Paclitaxel in Stage IIIB/IV Bronchioloalveolar Carcinoma

NCT00002969Phase 2Completed

Sponsor
SWOG Cancer Research Network
Start
May 1997
Primary completion
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel in bronchioloalveolar carcinoma (BAC), sponsored by SWOG Cancer Research Network. Started May 1997; status: completed.

02

Drugs

paclitaxel
03

Conditions

bronchioloalveolar carcinoma (BAC)

Beyond the preview

Go deeper on NCT00002969.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002969.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call